Generic semaglutide widens access, but doctors warn of misuse and quality risks
2026-03-23 - 07:59
As Indian pharmaceutical companies begin rolling out generic versions of semaglutide, a drug commonly prescribed for type 2 diabetes and obesity, patients are increasingly seeking it for weight loss rather than its intended medical use.
Share this post: